Dr. O’Neil is a molecular biologist with more than 15 years of research experience in molecular neuroscience, immunology, and genetic engineering. The major goal of his research program is to develop cell therapies that provide durable or curative treatments for disease. His previous work has been focused on studying the molecular etiology of neurological disorders and developing immune cell-based therapeutic platforms for applications in nephrology and oncology. These experiences have provided Dr. O’Neil with the broad knowledge of human physiology and pre-clinical models, as well as the expertise in genetic and cellular engineering, necessary to develop novel therapeutic approaches.
Richard Oneil, PhD
Vanderbilt University Medical Center
Cell and Gene Therapy
PhD, Neuroscience - Vanderbilt University, 2015
BS, Biology University of Georgia, 2005
Postdoc-Nephrology & Hypertension, Vanderbilt University Medical Center, 2019